CN Patent

CN1481236A — 气凝胶粉末治疗剂

Assigned to Aspen Aerogels Inc · Expires 2004-03-10 · 22y expired

What this patent protects

将以非常细的多孔气凝胶颗粒形式存在的药物通过吸入而对患者给药。该气凝胶颗粒是药物的气凝胶化形式，或沉积到用非无机氧化物载体基质材料如糖或碳水化合物所制造气凝胶颗粒产品上的气凝胶化形式。该气凝胶颗粒易于溶解于哺乳动物的肺部中所存在的肺表面活性剂中。

USPTO Abstract

将以非常细的多孔气凝胶颗粒形式存在的药物通过吸入而对患者给药。该气凝胶颗粒是药物的气凝胶化形式，或沉积到用非无机氧化物载体基质材料如糖或碳水化合物所制造气凝胶颗粒产品上的气凝胶化形式。该气凝胶颗粒易于溶解于哺乳动物的肺部中所存在的肺表面活性剂中。

Drugs covered by this patent

Patent Metadata

Patent number
CN1481236A
Jurisdiction
CN
Classification
—
Expires
2004-03-10
Drug substance claim
No
Drug product claim
No
Assignee
Aspen Aerogels Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.